T-cell lymphoma: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
|||
Line 41: | Line 41: | ||
==Treatment== | ==Treatment== | ||
[[T-cell lymphoma medical therapy|Medical therapy]] | [[T-cell lymphoma surgery|Surgery]] | [[T-cell lymphoma primary prevention|Primary Prevention]] | [[T-cell lymphoma secondary prevention|Secondary Prevention]] | [[T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | [[T-cell lymphoma medical therapy|Medical therapy]] | [[T-cell lymphoma surgery|Surgery]] | [[T-cell lymphoma primary prevention|Primary Prevention]] | [[T-cell lymphoma secondary prevention|Secondary Prevention]] | [[T-cell lymphoma cost-effectiveness of therapy|Cost-Effectiveness of Therapy]] | [[T-cell lymphoma future or investigational therapies|Future or Investigational Therapies]] | ||
==Case Studies== | |||
[[T-cell lymphoma case study one|Case #1]] | |||
==Related chapters== | ==Related chapters== |
Revision as of 15:40, 18 September 2012
For patient information click here.
T-cell lymphoma | |
MeSH | D016399 |
---|
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating T-cell lymphoma from other Diseases
Epidemiology and Demographics
Risk Factors
Screening
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms | Physical Examination | Staging | Laboratory Findings | X Ray | CT | MRI | Ultrasound | Other Imaging Findings | Other Diagnostic Studies
Treatment
Medical therapy | Surgery | Primary Prevention | Secondary Prevention | Cost-Effectiveness of Therapy | Future or Investigational Therapies
Case Studies
Related chapters